TVTX FY 2015 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$100M+254.2% YoY

Gross Profit

$98M97.8% margin

Operating Income

-$51M-50.8% margin

Net Income

$117M117.4% margin

EPS (Diluted)

$3.17

Cash Flow

Operating Cash Flow

-$554,000

Free Cash Flow

-$8M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$512M

Total Liabilities

$212M

Stockholders' Equity

$300M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$100M	$28M	+254.2%
Gross Profit	$98M	$28M	+253.6%
Operating Income	-$51M	-$80M	+36.4%
Net Income	$117M	-$111M	+205.7%